Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
5,593,860
-
Share change
-
+2,021,392
-
Total reported value
-
$59,684,256
-
Price per share
-
$10.67
-
Number of holders
-
24
-
Value change
-
+$21,023,976
-
Number of buys
-
10
-
Number of sells
-
6
Institutional Holders of SIERRA ONCOLOGY INC - COM NEW (SRRA) as of Q3 2020
As of 30 Sep 2020,
SIERRA ONCOLOGY INC - COM NEW (SRRA) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,593,860 shares.
The largest 10 holders included
Vivo Capital, LLC, ORBIMED ADVISORS LLC, CAXTON CORP, MANGROVE PARTNERS, Ikarian Capital, LLC, FRAZIER MANAGEMENT LLC, 683 Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.